RNN - 2.61 Pre-market now at 2.90/2.95 Rexahn Says Preliminary Data Show Bladder Cancer Drug Increases Progression Free Survival http://stockcharts.com/c-sc/sc?s=RNN&p=D&b=5&g=0&i=t01817346601&r=1505135468098 http://stockcharts.com/c-sc/sc?s=RNN&p=W&b=5&g=0&i=t89087294090&r=1505135503203